Biomaterials for Clinical Applications
This book is organized according to the World Health Organization’s report of the top 10 causes of death worldwide, and lays out opportunities for both biomaterials scientists and physicians to confront each of these leading contributors to mortality. The
- PDF / 9,615,418 Bytes
- 286 Pages / 439.37 x 666.142 pts Page_size
- 52 Downloads / 248 Views
Sujata K. Bhatia
Biomaterials for Clinical Applications
123
Sujata K. Bhatia Central Research and Development DuPont Company Wilmington, DE 19880-0262, USA [email protected]
ISBN 978-1-4419-6919-4 e-ISBN 978-1-4419-6920-0 DOI 10.1007/978-1-4419-6920-0 Springer New York Dordrecht Heidelberg London Library of Congress Control Number: 2010934220 © Springer Science+Business Media, LLC 2010 All rights reserved. This work may not be translated or copied in whole or in part without the written permission of the publisher (Springer Science+Business Media, LLC, 233 Spring Street, New York, NY 10013, USA), except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed is forbidden. The use in this publication of trade names, trademarks, service marks, and similar terms, even if they are not identified as such, is not to be taken as an expression of opinion as to whether or not they are subject to proprietary rights. Printed on acid-free paper Springer is part of Springer Science+Business Media (www.springer.com)
Preface
The field of biomaterials science currently faces an unprecedented opportunity to improve and save the lives of millions worldwide. A unique integration of chemistry, biology, engineering, and medicine, biomaterials science brings novel materials to bear on medical problems. The past few years have witnessed an explosion in the field of biomaterials, with an expansion of both the compositions and the applications of medical implant materials. While traditional biomaterials have been designed from polymers, ceramics, and metals, the newest generation of biomaterials incorporates biomolecules, therapeutic drugs, and living cells. At the same time that biomaterials science is advancing in the laboratory, the incidence of serious diseases is rising in the global community. The increasing proportion of older people in the global population is contributing to the increase of age-associated chronic diseases, including heart disease and cancer. Infectious diseases also represent a significant burden to global health; mortality from HIV/AIDS, tuberculosis, and infectious gastrointestinal diseases remains high. Physicians and biomedical researchers must be ready to address growing healthcare needs in every part of the world. Innovative biomedical materials will only reach the clinic if these technologies solve pressing clinical problems. Biomaterials scientists who wish to impact global health must first understand where the most urgent clinical needs lie. Translation of innovative technologies into clinical usage will require close collaboration between physicians and biomaterials scientists, so that scientists can address unmet clinical needs and physicians can appreciate novel technologies. The present volume aspires to bridge the gap between the laboratory and the clinic, by identifying needs for bi
Data Loading...
